1. Home
  2. COSM vs MBAI Comparison

COSM vs MBAI Comparison

Compare COSM & MBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cosmos Health Inc.

COSM

Cosmos Health Inc.

HOLD

Current Price

$0.32

Market Cap

13.5M

Sector

Health Care

ML Signal

HOLD

Logo Check-Cap Ltd. Ordinary Share

MBAI

Check-Cap Ltd. Ordinary Share

N/A

Current Price

$1.65

Market Cap

12.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
COSM
MBAI
Founded
2009
2004
Country
United States
Israel
Employees
N/A
85
Industry
Other Pharmaceuticals
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.5M
12.0M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
COSM
MBAI
Price
$0.32
$1.65
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
370.4K
45.2K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
45.58
N/A
EPS
N/A
N/A
Revenue
$54,426,402.00
N/A
Revenue This Year
$20.69
N/A
Revenue Next Year
$53.10
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.97
N/A
52 Week Low
$0.28
$1.31
52 Week High
$1.32
$3.92

Technical Indicators

Market Signals
Indicator
COSM
MBAI
Relative Strength Index (RSI) 36.76 45.49
Support Level $0.30 $1.44
Resistance Level $0.50 $1.83
Average True Range (ATR) 0.03 0.12
MACD 0.00 -0.01
Stochastic Oscillator 27.07 29.61

Price Performance

Historical Comparison
COSM
MBAI

About COSM Cosmos Health Inc.

Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.

About MBAI Check-Cap Ltd. Ordinary Share

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: